Skip to main content
Premium Trial:

Request an Annual Quote

Thermo Fisher Acquires Proxeon

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Thermo Fisher Scientific today announced that it has acquired proteomics tools firm Proxeon for an undisclosed sum.

The privately-held Danish firm makes nanoflow liquid chromatography systems, columns, ion sources, and bioinformatics software for liquid chromatography/mass spectrometry analysis in complex proteomics applications. Proxeon's primary product is its Easy-nLC nanoflow liquid chromatography system.

"By offering a high-performance solution that addresses the need for simplified operation, we can meet the increasing demand for LC/MS in proteomics applications," Thermo Fisher President and CEO Marc Casper said in a statement. "These systems can be easily integrated with our leading ion trap, hybrid and triple quadrupole mass spectrometry systems, in line with our strategy of providing comprehensive LC/MS solutions for both high-end research and routine applications."

Proxeon had 2009 revenues of around $10 million, according to Thermo Fisher. The firm, which employs approximately 40 people, will be integrated into Thermo Fisher's Analytical Technologies Segment.

Thermo Fisher said that it does not expect the purchase to have a material impact on its 2010 financial results.

The Scan

Interfering With Invasive Mussels

The Chicago Tribune reports that researchers are studying whether RNA interference- or CRISPR-based approaches can combat invasive freshwater mussels.

Participation Analysis

A new study finds that women tend to participate less at scientific meetings but that some changes can lead to increased involvement, the Guardian reports.

Right Whales' Decline

A research study plans to use genetic analysis to gain insight into population decline among North American right whales, according to CBC.

Science Papers Tie Rare Mutations to Short Stature, Immunodeficiency; Present Single-Cell Transcriptomics Map

In Science this week: pair of mutations in one gene uncovered in brothers with short stature and immunodeficiency, and more.